NEUROPRENE
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

NEUROPRENE Trademark

Serial Number: 79438399

NEUROPRENE is a trademark filed by Obshchestvo s ogranichennoy otvetstvennostyu on October 9, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Obshchestvo s ogranichennoy otvetstvennostyu (23 trademarks)

pomeshch. 35/1, str. 1,

Entity Type: 98

Trademark Details

Filing Date

October 9, 2025

Registration Date

Not Registered

Goods & Services

Demonstration of goods; providing business information via a website; providing commercial information and advice for consumers in the choice of products and services; provision of an online marketplace for buyers and sellers of goods and services; sales promotion for others; distribution of samples; dissemination of advertising matter; administrative processing of purchase orders; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; procurement services for others, namely, purchasing goods and services featuring pharmaceutical and medical supplies for other businesses; outsourcing services

Germicides; balms for medical purposes; dietetic foods adapted for medical use; guaiacol for pharmaceutical purposes; dietary supplements for human beings; mineral dietary supplements; nutritional supplements; albumin dietary supplements; dietary supplements for animals; yeast dietary supplements; alginate dietary supplements; glucose dietary supplements; casein dietary supplements; lecithin dietary supplements; linseed oil dietary supplements; brewer's yeast dietary supplements; propolis dietary supplements; protein dietary supplements; royal jelly dietary supplements; pollen dietary supplements; wheat germ dietary supplements; linseed dietary supplements; whey protein dietary supplements; dietary supplements with a cosmetic effect; enzyme dietary supplements; haemostatic pencils; medicinal roots; medicated hair lotions; skin lotions for pharmaceutical purposes; liniments; antibiotic ointments for pharmaceutical purposes; sunburn ointments; frostbite salve for pharmaceutical purposes; drugs for medical purposes, namely, for the treatment of neurodegenerative disease; herbal tinctures for medical purposes; mouthwashes for medical purposes; medicated toothpaste; balsamic preparations for medical purposes; vitamin preparations; diagnostic preparations for medical purposes; bath preparations for medical purposes; therapeutic preparations for the bath; pharmaceutical preparations for skin care; nutraceutical preparations for therapeutic or medical purposes for the treatment of neurodegenerative disease; aloe vera preparations for pharmaceutical purposes; pharmaceutical preparations for the treatment of neurodegenerative disease; pharmaceutical preparations for treating sunburn; enzyme preparations for medical purposes; phytotherapy preparations for medical purposes; neuroprotective pharmaceuticals; soporifics; antibacterial handwashes; adjuvants for medical purposes; astringents for medical purposes; vermifuges; disinfectants; depuratives for the body; appetite suppressants for medical purposes; medicated dentifrices; febrifuges; purgatives; remedies for foot perspiration, namely, medicated soap for foot perspiration; antiinflammatories; antiparasitic preparations; sedatives; laxatives;; medicated toiletry preparations; skin hydrators being injectable dermal fillers; digestives for pharmaceutical purposes; headache relief sticks; appetite suppressant pills; slimming pills; antioxidant pills being food supplements; medicinal herbs; tranquillizers; enzymes for medical purposes; ferments for pharmaceutical purposes; medicinal tea; herbal teas for medicinal purposes; bath tea for therapeutic purposes; medicated shampoos; medicated dry shampoos; herbal extracts, other than essential oils, for medical purposes; plant extracts, other than essential oils, for pharmaceutical purposes; ethers for pharmaceutical purposes; cellulose esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 21, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 21, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 21, 2026 TROA
REFUSAL PROCESSED BY IB
May 14, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 26, 2026 RFCS
REFUSAL PROCESSED BY MPU
Apr 25, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 14, 2026 RFCR
NON-FINAL ACTION WRITTEN
Mar 13, 2026 CNRT
ASSIGNED TO EXAMINER
Feb 26, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 8, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 8, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 4, 2025 REPR